Revolution Medicines Inc

Revolution Medicines Inc

RVMD

Market Cap$7.05B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Revolution Medicines IncRevolution Medicines Inc-10.2--34%36.40.1
$68.00

Target Price by Analysts

86.6% upsideRevolution Medicines Target Price DetailsTarget Price
$2.43

Current Fair Value

93.3% downside

Overvalued by 93.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$7.05 Billion
Enterprise Value$6.85 Billion
Dividend Yield$0 (0%)
Earnings per Share$-3.58
Beta1.1
Outstanding Shares188,145,904

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.22
PEG-12.16
Price to Sales36.44
Price to Book Ratio3.31
Enterprise Value to Revenue26.2
Enterprise Value to EBIT-8.68
Enterprise Value to Net Income-10
Total Debt to Enterprise0.02
Debt to Equity0.06

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Revolution Medicines Inc

CEO: Mark Goldsmith